The balance sheet appears robust with a debt-to-equity ratio improving to 0.39 and a current ratio of 2.80, though goodwill jumped to $1.3B in 2025Q1, posing potential impairment risk.
Ingredion Incorporated (INGR) balance sheet — 29-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 |
|---|
| Total Current Assets | 3.52B | 3.5B | 3.35B | 3.4B | 3.31B | 2.7B | 2.65B | 2.16B | 2.14B | 2.42B | 2.25B | 1.95B | 2.14B | 2.21B | 2.36B | 2.1B | 1.75B | 1.04B | 1.3B | 1.09B | 837M | 685M | 661M | 547M | 485M | 555M | 555M | 537M | 465M | 423M |
| Cash & Short-Term Investments | 952M | 1.03B | 1.01B | 409M | 239M | 332M | 665M | 268M | 334M | 604M | 516M | 440M | 614M | 574M | 628M | 401M | 302M | 175M | 107M | 175M | 131M | 116M | 101M | 70M | 36M | 65M | 41M | 41M | 36M | 85M |
| Cash Only | 948M | 1.03B | 997M | 401M | 236M | 328M | 665M | 264M | 327M | 595M | 512M | 434M | 580M | 574M | 609M | 401M | 302M | 175M | 107M | 175M | 131M | 116M | 101M | 70M | 36M | 65M | 41M | 41M | 36M | 85M |
| Short-Term Investments | 4M | 3M | 11M | 8M | 3M | 4M | 0 | 4M | 7M | 9M | 4M | 6M | 34M | 0 | 19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.39B | 1.02B | 1.09B | 1.28B | 1.41B | 1.13B | 1.01B | 977M | 951M | 961M | 923M | 775M | 762M | 832M | 814M | 837M | 735M | 440M | 627M | 460M | 357M | 287M | 291M | 252M | 244M | 279M | 274M | 261M | 224M | 175M |
| Days Sales Outstanding | 66.28 | 51.62 | 53.69 | 57.21 | 64.81 | 59.83 | 61.64 | 57.43 | 55.19 | 56.76 | 55.95 | 47.48 | 46.37 | 45.64 | 43.26 | 49.12 | 61.44 | 43.74 | 58.03 | 49.51 | 49.72 | 44.39 | 46.52 | 43.76 | 47.6 | 53.97 | 53.62 | 54.91 | 56.46 | 45.05 |
| Inventory | 1.11B | 1.23B | 1.19B | 1.45B | 1.6B | 1.17B | 917M | 861M | 824M | 823M | 789M | 715M | 699M | 723M | 834M | 769M | 678M | 394M | 454M | 427M | 321M | 258M | 258M | 215M | 194M | 201M | 232M | 212M | 175M | 123M |
| Days Inventory Outstanding | 78.66 | 83.07 | 76.83 | 82.55 | 90.34 | 76.9 | 70.99 | 64.17 | 61.12 | 62.95 | 61.52 | 55.34 | 52.25 | 47.79 | 54.07 | 51.81 | 63.32 | 45.63 | 51.16 | 55.56 | 53.14 | 46.43 | 48.82 | 44.14 | 44.15 | 46.2 | 54.32 | 53.37 | 54.04 | 38.14 |
| Other Current Assets | 0 | 164M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48M | 68M | 65M | 71M | 18M | 23M | 99M | 13M | 16M | 13M | 0 | 0 | 0 | 0 | 0 | 23M | 30M | 40M |
| Total Non-Current Assets | 4.55B | 4.39B | 4.09B | 4.24B | 4.25B | 4.3B | 4.21B | 3.88B | 3.59B | 3.67B | 3.53B | 3.12B | 2.95B | 3.15B | 3.23B | 3.21B | 3.32B | 1.91B | 1.91B | 2.01B | 1.82B | 1.7B | 1.71B | 1.66B | 1.53B | 1.67B | 1.78B | 1.68B | 1.48B | 1.24B |
| Property, Plant & Equipment | 2.52B | 2.53B | 2.26B | 2.37B | 2.41B | 2.42B | 2.46B | 2.46B | 2.2B | 2.22B | 2.12B | 1.99B | 2.07B | 2.16B | 2.19B | 2.16B | 2.12B | 1.56B | 1.45B | 1.5B | 1.36B | 1.27B | 1.21B | 1.19B | 1.15B | 1.29B | 1.41B | 1.35B | 1.3B | 1.06B |
| Fixed Asset Turnover | 2.87x | 2.86x | 3.28x | 3.44x | 3.30x | 2.85x | 2.44x | 2.53x | 2.86x | 2.79x | 2.85x | 3.00x | 2.89x | 3.09x | 3.13x | 2.88x | 2.06x | 2.35x | 2.73x | 2.26x | 1.93x | 1.85x | 1.89x | 1.77x | 1.62x | 1.46x | 1.33x | 1.29x | 1.12x | 1.34x |
| Goodwill | 917M | 0 | 906M | 918M | 900M | 914M | 902M | 801M | 791M | 803M | 784M | 601M | 478M | 535M | 557M | 562M | 635M | 238M | 351M | 426M | 381M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 337M | 1.27B | 358M | 385M | 401M | 434M | 444M | 437M | 460M | 493M | 502M | 410M | 290M | 311M | 329M | 347M | 364M | 7M | 8M | 0 | 0 | 359M | 353M | 319M | 280M | 283M | 313M | 270M | 129M | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5M | 11M | 10M | 10M | 12M | 10M | 7M | 13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 772M | 597M | 561M | 570M | 544M | 531M | 387M | 172M | 131M | 143M | 121M | 117M | 91M | 118M | 122M | 121M | 113M | 85M | 93M | 74M | 70M | 68M | 77M | 96M | 90M | 76M | 62M | 73M | 54M | 186M |
| Total Assets | 8.07B | 7.9B | 7.44B | 7.64B | 7.56B | 7B | 6.86B | 6.04B | 5.73B | 6.08B | 5.78B | 5.07B | 5.09B | 5.36B | 5.59B | 5.32B | 5.07B | 2.95B | 3.21B | 3.1B | 2.66B | 2.39B | 2.37B | 2.21B | 2.02B | 2.23B | 2.34B | 2.21B | 1.95B | 1.67B |
| Asset Turnover | 0.91x | 0.91x | 1.00x | 1.07x | 1.05x | 0.98x | 0.87x | 1.03x | 1.10x | 1.02x | 1.04x | 1.17x | 1.18x | 1.24x | 1.23x | 1.17x | 0.86x | 1.24x | 1.23x | 1.09x | 0.98x | 0.99x | 0.96x | 0.95x | 0.93x | 0.85x | 0.80x | 0.78x | 0.74x | 0.85x |
| Asset Growth % | 20.05% | 6.09% | -2.59% | 1.07% | 8.03% | 2.06% | 13.54% | 5.45% | -5.79% | 5.15% | 13.95% | -0.33% | -5.02% | -4.15% | 5.17% | 4.85% | 71.78% | -7.95% | 3.35% | 16.57% | 11.43% | 0.93% | 7.1% | 9.68% | -9.52% | -4.79% | 5.74% | 13.67% | 16.81% | - |
| Total Current Liabilities | 1.26B | 1.32B | 1.28B | 1.77B | 1.88B | 1.51B | 1.46B | 967M | 946M | 957M | 978M | 742M | 721M | 820M | 933M | 926M | 891M | 565M | 859M | 674M | 517M | 424M | 462M | 394M | 347M | 675M | 486M | 421M | 405M | 496M |
| Accounts Payable | 1.22B | 1.27B | 604M | 778M | 873M | 774M | 599M | 504M | 452M | 493M | 440M | 423M | 430M | 458M | 590M | 529M | 535M | 319M | 528M | 382M | 429M | 263M | 374M | 200M | 164M | 143M | 136M | 109M | 96M | 90M |
| Days Payables Outstanding | 71.63 | 85.85 | 39.1 | 44.29 | 49.39 | 50.78 | 46.37 | 37.57 | 33.53 | 37.71 | 34.31 | 32.74 | 32.14 | 30.27 | 38.25 | 35.64 | 49.97 | 36.94 | 59.5 | 49.71 | 71.01 | 47.33 | 70.77 | 41.06 | 37.32 | 32.87 | 31.84 | 27.44 | 29.64 | 27.91 |
| Short-Term Debt | 41M | 48M | 44M | 448M | 543M | 308M | 438M | 82M | 169M | 120M | 106M | 19M | 23M | 93M | 76M | 148M | 88M | 136M | 206M | 130M | 74M | 57M | 88M | 98M | 84M | 444M | 267M | 222M | 250M | 337M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 124M | 172M | 112M | 105M | 96M | 93M | 81M | 101M | 107M | 84M | 74M | 75M | 92M | 85M | 12M | 9M | 0 | 28M | -104M | 1M | -113M | 0 | 0 | 0 | 0 | 90M | 59M | 69M |
| Current Ratio | 2.80x | 2.66x | 2.62x | 1.92x | 1.76x | 1.78x | 1.82x | 2.23x | 2.26x | 2.52x | 2.30x | 2.63x | 2.97x | 2.70x | 2.53x | 2.27x | 1.97x | 1.85x | 1.51x | 1.62x | 1.62x | 1.62x | 1.43x | 1.39x | 1.40x | 0.82x | 1.14x | 1.28x | 1.15x | 0.85x |
| Quick Ratio | 1.92x | 1.73x | 1.69x | 1.10x | 0.91x | 1.01x | 1.19x | 1.34x | 1.39x | 1.66x | 1.50x | 1.66x | 2.00x | 1.82x | 1.64x | 1.44x | 1.21x | 1.15x | 0.98x | 0.98x | 1.00x | 1.01x | 0.87x | 0.84x | 0.84x | 0.52x | 0.66x | 0.77x | 0.72x | 0.60x |
| Cash Conversion Cycle | 73.32 | 48.85 | 91.43 | 95.47 | 105.77 | 85.94 | 86.25 | 84.04 | 82.79 | 82 | 83.16 | 70.08 | 66.48 | 63.16 | 59.08 | 65.29 | 74.79 | 52.42 | 49.69 | 55.37 | 31.84 | 43.49 | 24.58 | 46.84 | 54.43 | 67.3 | 76.1 | 80.84 | 80.86 | 55.28 |
| Total Non-Current Liabilities | 2.24B | 2.21B | 2.27B | 2.22B | 2.42B | 2.26B | 2.33B | 2.3B | 2.37B | 2.21B | 2.21B | 2.15B | 2.16B | 2.11B | 2.2B | 2.26B | 2.18B | 683M | 942M | 803M | 779M | 738M | 806M | 833M | 858M | 548M | 685M | 567M | 397M | 178M |
| Long-Term Debt | 1.74B | 1.74B | 1.79B | 1.74B | 1.94B | 1.74B | 1.75B | 1.76B | 1.93B | 1.74B | 1.85B | 1.81B | 1.78B | 1.7B | 1.7B | 1.78B | 1.68B | 408M | 660M | 519M | 480M | 471M | 480M | 452M | 516M | 312M | 453M | 322M | 154M | 13M |
| Capital Lease Obligations | 0 | 0 | 145M | 157M | 146M | 154M | 136M | 120M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 136M | 116M | 145M | 165M | 217M | 195M | 189M | 199M | 171M | 135M | 180M | 207M | 160M | 199M | 249M | 111M | 105M | 133M | 121M | 128M | 177M | 210M | 163M | 186M | 185M | 180M | 180M | 128M |
| Other Non-Current Liabilities | 496M | 473M | 205M | 207M | 186M | 205M | 227M | 221M | 253M | 264M | 191M | 201M | 192M | 200M | 336M | 277M | 248M | 164M | 177M | 151M | 178M | 139M | 149M | 185M | 153M | 50M | 47M | 63M | 63M | 37M |
| Total Liabilities | 3.54B | 3.53B | 3.55B | 3.99B | 4.3B | 3.77B | 3.79B | 3.27B | 3.32B | 3.16B | 3.19B | 2.89B | 2.88B | 2.93B | 3.13B | 3.18B | 3.07B | 1.25B | 1.8B | 1.48B | 1.3B | 1.16B | 1.27B | 1.23B | 1.21B | 1.22B | 1.17B | 988M | 802M | 674M |
| Total Debt | 1.78B | 1.79B | 2.04B | 2.4B | 2.68B | 2.25B | 2.37B | 2.01B | 2.1B | 1.86B | 1.95B | 1.83B | 1.81B | 1.8B | 1.78B | 1.93B | 1.77B | 544M | 866M | 649M | 554M | 528M | 568M | 550M | 600M | 756M | 720M | 544M | 404M | 350M |
| Net Debt | 835M | 760M | 1.04B | 2B | 2.44B | 1.92B | 1.7B | 1.74B | 1.77B | 1.27B | 1.44B | 1.4B | 1.23B | 1.22B | 1.17B | 1.53B | 1.47B | 369M | 759M | 474M | 423M | 412M | 467M | 480M | 564M | 691M | 679M | 503M | 368M | 265M |
| Debt / Equity | 0.39x | 0.41x | 0.52x | 0.66x | 0.82x | 0.70x | 0.77x | 0.72x | 0.87x | 0.64x | 0.75x | 0.84x | 0.82x | 0.74x | 0.72x | 0.90x | 0.88x | 0.32x | 0.62x | 0.40x | 0.41x | 0.43x | 0.52x | 0.56x | 0.70x | 0.75x | 0.62x | 0.44x | 0.35x | 0.35x |
| Debt / EBITDA | 1.56x | 1.42x | 1.86x | 2.04x | 2.74x | 4.24x | 2.98x | 2.27x | 2.21x | 1.78x | 1.95x | 2.14x | 2.33x | 2.23x | 2.03x | 2.19x | 3.58x | 1.92x | 1.54x | 1.38x | 1.64x | 1.83x | 2.02x | 2.00x | 2.34x | 2.58x | 2.47x | 1.95x | 2.45x | 2.32x |
| Net Debt / EBITDA | 0.73x | 0.60x | 0.95x | 1.70x | 2.50x | 3.62x | 2.14x | 1.97x | 1.87x | 1.21x | 1.44x | 1.64x | 1.58x | 1.52x | 1.33x | 1.73x | 2.97x | 1.30x | 1.35x | 1.00x | 1.25x | 1.43x | 1.66x | 1.75x | 2.20x | 2.36x | 2.33x | 1.80x | 2.23x | 1.75x |
| Interest Coverage | 33.68x | 27.32x | 24.87x | 8.36x | 7.75x | 4.35x | 7.25x | 7.53x | 8.67x | 10.73x | 11.16x | 9.68x | 8.12x | 8.39x | 8.81x | 8.71x | 5.36x | 3.94x | 10.42x | 7.55x | 7.23x | 6.54x | 3.03x | 3.48x | 5.46x | 2.27x | 1.79x | 5.61x | 35.00x | 0.35x |
| Total Equity | 4.52B | 4.37B | 3.89B | 3.65B | 3.26B | 3.23B | 3.07B | 2.77B | 2.41B | 2.92B | 2.6B | 2.18B | 2.21B | 2.43B | 2.46B | 2.13B | 2B | 1.7B | 1.41B | 1.63B | 1.35B | 1.23B | 1.1B | 989M | 863M | 1B | 1.17B | 1.23B | 1.14B | 992M |
| Equity Growth % | 35.16% | 12.24% | 6.58% | 11.89% | 1.15% | 4.98% | 10.82% | 15.12% | -17.45% | 12.41% | 19.04% | -1.22% | -9.14% | -1.22% | 15.28% | 6.54% | 17.49% | 21.19% | -13.53% | 20.53% | 9.94% | 11.65% | 11.12% | 14.6% | -14.04% | -14.04% | -4.96% | 7.43% | 15.32% | - |
| Book Value per Share | 70.80 | 66.96 | 58.41 | 54.48 | 48.69 | 47.57 | 45.44 | 41.13 | 33.54 | 39.69 | 35.02 | 29.86 | 29.47 | 31.02 | 31.45 | 27.28 | 26.07 | 22.57 | 18.52 | 21.25 | 17.80 | 16.23 | 14.71 | 13.66 | 12.09 | 14.14 | 16.54 | 16.43 | 15.84 | 13.89 |
| Total Shareholders' Equity | 4.52B | 4.34B | 3.86B | 3.59B | 3.19B | 3.14B | 2.98B | 2.75B | 2.39B | 2.89B | 2.56B | 2.14B | 2.18B | 2.4B | 2.44B | 2.1B | 1.98B | 1.68B | 1.38B | 1.6B | 1.33B | 1.21B | 1.08B | 911M | 770M | 857M | 960M | 1.03B | 1.05B | 986M |
| Common Stock | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 0 | 0 |
| Retained Earnings | 5.76B | 5.61B | 5.09B | 4.65B | 4.21B | 3.9B | 3.96B | 3.78B | 3.54B | 3.26B | 2.9B | 2.55B | 2.27B | 2.04B | 1.77B | 1.41B | 1.05B | 919M | 921M | 694M | 528M | 429M | 360M | 285M | 224M | 175M | 132M | 101M | 37M | 0 |
| Treasury Stock | -1.55B | -1.55B | -1.35B | -1.21B | -1.15B | -1.06B | -1.02B | -1.04B | -1.09B | -494M | -413M | -467M | -481M | -225M | -6M | -42M | -1M | -13M | -29M | -57M | -27M | -36M | -4M | -35M | -48M | -56M | -60M | -20M | 0 | 0 |
| Accumulated OCI | -848M | -937M | -1.09B | -1.06B | -1.05B | -897M | -1.13B | -1.16B | -1.15B | -1.01B | -1.07B | -1.1B | -782M | -583M | -475M | -413M | -190M | -308M | -595M | -115M | -223M | -252M | -323M | -346M | -422M | -336M | -186M | -122M | -1.35B | -1.14B |
| Minority Interest | 0 | 28M | 26M | 57M | 67M | 89M | 91M | 21M | 20M | 26M | 30M | 36M | 30M | 25M | 22M | 29M | 26M | 23M | 22M | 21M | 19M | 17M | 18M | 78M | 93M | 147M | 208M | 199M | 91M | 6M |
Quick answers to the most common questions about buying INGR stock.
As of 2025, Ingredion Incorporated (INGR) had total assets of $7.90B including $3.50B in current assets.
Ingredion Incorporated (INGR) carries total debt of $1.79B, offset by $1.03B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Ingredion Incorporated (INGR) has total shareholders' equity (book value) of $4.34B ($66.96 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Ingredion Incorporated (INGR) reported a current ratio of 2.66x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Goodwill impairment and margin pressure
Metrics are mathematically derived from official filings.
Balance Sheet Strengthens Amid Revenue Decline
Ingredion's total assets grew from $7.3B in 2024Q1 to $8.1B in 2026Q2, while equity expanded from $3.8B to $4.5B, according to reported balance sheet data, indicating a strengthening financial position despite persistent revenue contraction.
The sequential increase in total assets and equity, driven by retained earnings accumulation, suggests that the company is building a larger capital base even as top-line growth remains negative. This implies that management is prioritizing balance sheet resilience over aggressive expansion, which may support future strategic moves or buffer against commodity volatility. However, the growth in assets is partly attributable to a rise in goodwill, which warrants monitoring for potential impairment.
Leverage Eases as Debt Repaid
Ingredion's debt-to-equity ratio improved from 0.49 in 2024Q1 to 0.39 in 2026Q2, with total debt declining from $1.9B to $1.8B, as per balance sheet data, reflecting a conservative leverage posture.
The reduction in leverage, combined with a stable absolute debt level, suggests that the company is managing its capital structure prudently, likely to maintain financial flexibility in a volatile commodity environment. The D/E ratio of 0.39 is lower than peers like ADM (0.42) and significantly below Avery Dennison (1.66), indicating a relatively low refinancing risk. This conservative approach may limit interest expense exposure, but it also implies that the company is not aggressively leveraging to fund growth, which could be a constraint in pursuing larger acquisitions.
Asset Mix Shifts Toward Intangibles
Goodwill jumped from $906M in 2024Q4 to $1.3B in 2025Q1, while PPE net increased from $2.3B to $2.5B over the same period, based on reported balance sheet figures, signaling a strategic pivot toward specialty ingredients.
The significant increase in goodwill likely reflects acquisitions in the texture and healthful solutions space, such as TIC Gums and PureCircle, which are intended to enhance the company's specialty portfolio. This shift implies a greater reliance on intangible assets, which carry impairment risk if the expected synergies or growth rates fail to materialize. Meanwhile, the steady growth in PPE suggests continued investment in wet-milling capacity, but the rising capital intensity (as noted in cash flow analysis) may pressure free cash flow if utilization rates do not improve.
Retained Earnings Drive Equity Growth
Retained earnings rose from $4.8B in 2024Q1 to $5.8B in 2026Q2, contributing to a $0.7B increase in total equity, as reported in Ingredion's balance sheet, underscoring the role of profit retention in capital accumulation.
The consistent growth in retained earnings, despite negative revenue trends, indicates that the company is generating sufficient profitability to reinvest in the business and support shareholder returns. However, the prior cash flow analysis revealed that cumulative operating cash flow ($2.5B) exceeds cumulative net income ($1.6B) over the last ten quarters, suggesting that earnings quality may be higher than reported due to non-cash items. The equity base is solid, but the reliance on retained earnings rather than new issuance implies that dilution is not a concern, which is positive for existing shareholders.
Liquidity Buffer Strengthens
Ingredion's current ratio improved from 2.44 in 2024Q1 to 2.80 in 2026Q2, with cash increasing from $438M to $948M, according to balance sheet data, providing a robust cushion against operational shocks.
The substantial improvement in liquidity, driven by higher cash balances and a current ratio well above 2.0, suggests that the company is well-positioned to meet short-term obligations and weather commodity price volatility. This buffer is particularly important given the negative free cash flow in recent quarters, as it provides a cushion for ongoing capital expenditures and dividend payments. However, the cash pile is still modest relative to total debt ($1.8B), so the company may need to rely on credit facilities if cash generation does not recover.
Goodwill Impairment Risk Looms
Goodwill increased by $394M in 2025Q1, reaching $1.3B, and remains elevated at $917M in 2026Q2, as per balance sheet data, representing a potential impairment risk if specialty growth underperforms.
The sharp rise in goodwill, likely from acquisitions, suggests that Ingredion is paying a premium for growth in texture and healthful solutions. If these businesses fail to achieve projected revenue or margin targets, the company may be forced to recognize impairment charges, which would erode equity and earnings. Given the recent revenue decline and the slower-than-anticipated adoption of plant-based proteins, investors should monitor the performance of these acquired entities closely. The absence of deferred revenue data also limits visibility into future revenue streams, adding to the uncertainty.